Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta‐analysis

Abstract Aims Several mechanisms have been identified in the aetiopathogenesis of heart failure with preserved ejection fraction (HFpEF). Among these, coronary microvascular dysfunction (CMD) may play a key pathophysiological role. We performed a systematic review and meta‐analysis to investigate th...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	ESC Heart Failure
المؤلفون الرئيسيون:	Domenico D'Amario, Renzo Laborante, Emiliano Bianchini, Giuseppe Ciliberti, Donato Antonio Paglianiti, Mattia Galli, Attilio Restivo, Davide Stolfo, Rocco Vergallo, Giuseppe M.C. Rosano, Filippo Crea, Carolyn S.P. Lam, Lars H. Lund, Marco Metra, Giuseppe Patti, Gianluigi Savarese
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Wiley 2024-08-01
الموضوعات:	Coronary microvascular dysfunction Diastolic dysfunction HFpEF
الوصول للمادة أونلاين:	https://doi.org/10.1002/ehf2.14626

مواد مشابهة

The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction
حسب: Clement Lau, وآخرون
منشور في: (2022-07-01)

Mice with endothelial cell‐selective adhesion molecule deficiency develop coronary microvascular rarefaction and left ventricle diastolic dysfunction
حسب: Vadym Buncha, وآخرون
منشور في: (2023-03-01)

The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles
حسب: Michiel T.H.M. Henkens, وآخرون
منشور في: (2022-06-01)

Sacubitril/valsartan improves diastolic left ventricular stiffness with increased titin phosphorylation via cGMP-PKG activation in diabetic mice
حسب: Nozomi Furukawa, وآخرون
منشور في: (2024-10-01)

Leucine Supplementation Prevents the Development of Skeletal Muscle Dysfunction in a Rat Model of HFpEF
حسب: Paula Ketilly Nascimento Alves, وآخرون
منشور في: (2024-03-01)

Mural cell dysfunction contributes to diastolic heart failure by promoting endothelial dysfunction and vessel remodelling
حسب: Mandy O. J. Grootaert, وآخرون
منشور في: (2025-02-01)

Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition
حسب: Paula Ketilly Nascimento Alves, وآخرون
منشور في: (2023-11-01)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
حسب: Nicole Habel, وآخرون
منشور في: (2023-06-01)

Gender-Specific Differences in Diastolic Dysfunction and HFpEF: Pathophysiology, Diagnosis, and Therapeutic Strategies
حسب: Francesca Coppi, وآخرون
منشور في: (2025-06-01)

Impact of epicardial adipose tissue on cardiac function and morphology in patients with diastolic dysfunction
حسب: Alexander Schulz, وآخرون
منشور في: (2024-08-01)

NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
حسب: James P. Teuber, وآخرون
منشور في: (2022-09-01)

Carbohydrate antigen-125 (CA125): a marker of right ventricular dysfunction and poor prognosis in heart failure with preserved ejection fraction
حسب: Sher May Ng, وآخرون
منشور في: (2025-10-01)

Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility
حسب: Volker Adams, وآخرون
منشور في: (2022-06-01)

Epicardial fat volume assessment via cardiac computed tomography: a novel indicator in heart failure with preserved ejection fraction
حسب: Hanaa Mahmoud Mohammad Abdelaziz, وآخرون
منشور في: (2025-02-01)

Left Atrial Strain in Patients with Chronic Heart Failure with Preserved Ejection Fraction: A Narrative Review
حسب: Dana Emilia Man, وآخرون
منشور في: (2025-02-01)

Heart failure: an update from the last years and a look at the near future
حسب: Mauro Riccardi, وآخرون
منشور في: (2022-12-01)

Plasma trimethylamine n-oxide is associated with renal function in patients with heart failure with preserved ejection fraction
حسب: Fei Guo, وآخرون
منشور في: (2020-08-01)

Nitric oxide metabolites: associations with cardiovascular biomarkers and clinical parameters in patients with HFpEF
حسب: Karsten Piatek, وآخرون
منشور في: (2022-12-01)

Distinct implications of body mass index in different subgroups of nonobese patients with heart failure with preserved ejection fraction: a latent class analysis of data from the TOPCAT trial
حسب: Bin Dong, وآخرون
منشور في: (2022-11-01)

Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction
حسب: Mikael Erhardsson, وآخرون
منشور في: (2023-12-01)

Cardiometabolic Phenotype in HFpEF: Insights from Murine Models
حسب: Ekaterina Ogurtsova, وآخرون
منشور في: (2025-03-01)

Phenotyping patients with chronic obstructive pulmonary disease and heart failure
حسب: Peter Moritz Becher, وآخرون
منشور في: (2025-04-01)

Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future
حسب: Kyle B. LaPenna, وآخرون
منشور في: (2021-03-01)

Identification of ageing-associated gene signatures in heart failure with preserved ejection fraction by integrated bioinformatics analysis and machine learning
حسب: Guoxing Li, وآخرون
منشور في: (2025-07-01)

Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction
حسب: Satyam Sarma, وآخرون
منشور في: (2020-11-01)

The role of coronary microvascular dysfunction in the pathogenesis of heart failure with preserved ejection fraction
حسب: Becker Al-Khayatt, وآخرون
منشور في: (2024-05-01)

Heart failure with preserved ejection fraction: diagnostic value of HFA-PEFF score, H₂FPEF score, and the diastolic stress echocardiography
حسب: Andrzej Kubicius, وآخرون
منشور في: (2024-10-01)

Relation of left atrial overload indices with prognostic endpoints in heart failure and preserved ejection fraction
حسب: Shiro Hoshida, وآخرون
منشور في: (2022-06-01)

The assessment of left ventricular diastolic function: guidance and recommendations from the British Society of Echocardiography
حسب: Shaun Robinson, وآخرون
منشور في: (2024-06-01)

Diastolic Cardiac Function by MRI—Imaging Capabilities and Clinical Applications
حسب: El-Sayed H. Ibrahim, وآخرون
منشور في: (2021-12-01)

Mitochondrial dysfunction as a therapeutic nexus in HFpEF: therapeutic target and pharmacological advances
حسب: Tian Yue, وآخرون
منشور في: (2025-09-01)

Sodium Glucose Transporter 2 Inhibitor Protects Against Heart Failure With Preserved Ejection Fraction: Preclinical “2‐Hit” Model Reveals Autophagy Enhancement Via AMP‐Activated Protein Kinase/Mammalian Target of Rapamycin Complex 1 Pathway
حسب: Xinyu Hu, وآخرون
منشور في: (2025-08-01)

Clinical profile of heart failure in geriatric patients in a tertiary cardiac hospital of Bangladesh
حسب: Mahbuba Yesmin, وآخرون
منشور في: (2025-06-01)

Effects of Continuous Accelerated Pacing on Cardiac Structure and Function in Patients With Heart Failure With Preserved Ejection Fraction: Insights From the myPACE Randomized Clinical Trial
حسب: Kramer J. Wahlberg, وآخرون
منشور في: (2024-01-01)

Multimodality assessment of heart failure with preserved ejection fraction skeletal muscle reveals differences in the machinery of energy fuel metabolism
حسب: Payman Zamani, وآخرون
منشور في: (2021-08-01)

Prognostic significance of the HFA‐PEFF score in patients with heart failure with preserved ejection fraction
حسب: Yohei Sotomi, وآخرون
منشور في: (2021-06-01)

Dantrolene improves left ventricular diastolic property in mineralcorticoid-salt-induced hypertensive rats
حسب: Junya Nawata, وآخرون
منشور في: (2023-07-01)

Hospitalized patients and stimulant use-associated heart failure: importance of ejection fraction and related risk factors
حسب: Akshat Agrawal, وآخرون
منشور في: (2025-07-01)

Bibliometric and visual analysis of coronary microvascular dysfunction
حسب: Xiaoxiao Lin, وآخرون
منشور في: (2022-11-01)

Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP‐HF registry
حسب: Matteo Pagnesi, وآخرون
منشور في: (2024-02-01)